Combinostics Oy
About Combinostics Oy
Combinostics Oy is a Finnish healthcare AI company that develops and markets advanced tools for data-driven diagnostics, primarily focusing on neurological disorders. Their flagship product, the cNeuro® platform, offers a suite of AI-powered applications designed to assist clinicians in the early detection, differential diagnosis, and ongoing management of conditions such as Alzheimer’s disease, other dementias, multiple sclerosis, traumatic brain injuries, and epilepsy.
The cNeuro platform integrates imaging data with clinical information to provide a comprehensive and intuitive view of patient data. Key applications include cNeuro® cMRI™ for automated quantification of brain MRI scans, cNeuro® cDSI™ for data-driven clinical decision support by combining imaging and clinical biomarkers with a database of previously diagnosed patients, cNeuro® cPET™ for automated FDG and amyloid PET quantification, and cNeuro® cDAT™ for automated quantification of DAT SPECT images to aid in the diagnosis of Parkinson’s disease and Dementia with Lewy Bodies. These tools aim to enhance diagnostic accuracy, improve treatment choices, and ultimately improve the quality of life for patients with neurological disorders.
Focus Areas
Business Intelligence
| Technology | cloud-based, AI-driven platform (cNeuro) |
What Physicians Need to Know
Combinostics' solutions empower physicians with objective, reliable, and evidence-based insights for confident diagnostic and management decisions. The AI-powered quantification of MRI and PET scans helps identify subtle changes difficult to assess visually, leading to earlier and more accurate diagnoses. The Dementia Differential Analysis report is particularly valuable for distinguishing between different types of dementia. The integration of various patient data points provides a holistic view, aiding in treatment planning, monitoring disease progression, and making informed decisions about additional testing. The clinically focused reports also facilitate better communication between radiologists, neurologists, patients, and caregivers.
The cNeuro® platform is cloud-based and designed to integrate cMRI™ and cDSI™ applications with multiple external data sources. Combinostics has partnered with ConcertAI's TeraRecon to make their cMRI™ solution available within the Eureka Clinical AI platform, enhancing seamless workflow integration for approximately 1900 health sites globally. The cDSI application can combine imaging and other biomarkers, clinical tests, neuropsychological tests, and demographic data.
What the Web Says
Combinostics Oy is a Finnish company specializing in AI-powered solutions for neurological disorders, particularly in the diagnosis and management of dementia and multiple sclerosis. Their flagship product, cNeuro, offers multimodal clinical decision support tools that integrate brain MRI analysis with other clinical data. The company was acquired by SyntheticMR in November 2024. While specific user reviews from platforms like G2, Glassdoor, Capterra, and Reddit are not readily available, the company's products are highlighted for their ability to provide objective data and support early diagnosis and efficient management of neurodegenerative diseases.
Overall: MixedStrengths
- AI-driven, cloud-based diagnostics for neurological disorders.
- Integrates brain MRI analysis with clinical data like CSF results.
- Supports early diagnosis and efficient management of neurodegenerative diseases.
- Provides quantified information for differential diagnosis and assessing cognitive issues.
- Enhances workflow for radiologists and provides detailed reports.
- Facilitates communication between radiologists and clinicians.
Limitations
- Limited public reviews available on major platforms like G2, Glassdoor, Capterra, and Reddit.
- Acquisition by SyntheticMR for less than it raised suggests potential financial challenges prior to the merger.
- The broader funding environment has been challenging for healthtech AI startups without strong commercial traction.
- SyntheticMR's reported revenue decline could pose short-term challenges for the combined company.
Based on reviews from: Combinostics Official Website, Medium (Amine Korchi MD), Medical Technology Yearbook, Medical Technology Issue 32, accessdata.fda.gov
Last updated: 2026-10-20
Videos
News, demos, and interviews about Combinostics Oy.
Videos load interactively. If none appear, search YouTube for Combinostics Oy →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]